Smaller, more frequent and more focused ICH public meetings in lieu of the previously organised international ICH Conferences are now organised in the ICH regions.

These public meetings are organised either as ICH-branded regional meetings and sometimes in collaboration with other non-profit organisations.

  • 2016 Events

    • Location :

      Tokyo, Japan

      Date :

      12 November 2016

      Description :

      An ICH/DIA joint workshop will be held on November 12, 2016 in Tokyo, Japan following the ICH Osaka meeting (November 5-10, 2016) and preceding the DIA Japan Annual Meeting (November 13-15, 2016).

       

      This workshop aims to provide an opportunity to share major outcomes from the ICH Osaka Meeting as well as to discuss its implications.

       

      More information on this meeting can be found on the programme.

    • Location :

      Ottawa, Ontario, Canada

      Date :

      24 October 2016

      Description :

      Health Canada and the U.S. Food and Drug Administration (FDA) hold joint public consultation meetings on ICH Guidelines currently under development prior to each bi-annual ICH face-to-face meeting, in order to seek input on areas of current regulatory disharmony and where harmonised ICH Guidelines would be beneficial.

       

      The next meeting will take place on October 24, 2016, 1pm-3pm, at the Tunney’s Pasture campus of Health Canada in Ottawa, Ontario. Stakeholders will also be able to participate by webcast. An ICH/DIA joint workshop will be held on November 12, 2016 in Tokyo, Japan following the ICH Osaka meeting (November 5-10, 2016) and preceding the DIA Japan Annual Meeting (November 13-15, 2016).

      More information on this meeting can be found on the Health Canada website.

    • Location :

      Hambourg, Germany

      Date :

      6 April 2016

      Description :

      This ICH Information Day entitled “ICH Goes Global – ICH Reforms & How They Affect You” is jointly organised by the European Commission (EC), the European Medicines Agency (EMA) and the Drug Information Association (DIA). The Information Day will focus on the recent reforms by ICH and what this means for global development of medicines. Participants will hear how ICH is moving towards being a truly global platform for regulators and industry to achieve the objective of ‘Harmonisation for Better Health’. More information on this meeting can be found on the DIA website.

    • Location :

      Tokyo, Japan

      Date :

      15 January 2016

      Description :

      The 33rd ICH public meeting was held in Japan which took place at the Zendentsu Hall, Chiyoda-ku in Tokyo on January 15, 2016.

       

      This public meeting aims to provide an opportunity to update the public on the information of the progress made during the ICH meeting in Jacksonville from December 5 to 10, 2015. At the beginning, we had presentations about the establishment of the ICH Association then move to the topic on the status of various ICH Guidelines, under development with Q & A session.

       

      The public meeting was jointly organized by the Japan Pharmaceutical Manufacturers Association (JPMA) and the Pharmaceutical and Medical Device Regulatory Science Society of Japan (PMRJ, non-profit organization), and supported by the Federation of Pharmaceutical Manufacturers’ Associations of Japan, the Pharmaceutical Manufacturers’ Association of Tokyo, Osaka Pharmaceutical Manufacturers Association and Japan Pharmaceutical Association.

       

      More information on this meeting can be found on the JPMA website.

  • Past Events

    • Location :

      Tokyo, Japan

      Date :

      23 July 2015

      Description :

      An ICH regional public meeting entitled ICH Japan Symposium 2015 (The 32nd ICH public meeting) was held in Japan which took place at the Zendentsu Hall, Chiyoda-ku in Tokyo in July 23, 2015.

       

      This public meeting aims to provide an opportunity to update to the public on the information of the progress made during the ICH meeting in Fukuoka in June 5-11, 2015 and on the status of the various ICH Guidelines including ICH Reform under development with Q & A session.

       

      The public meeting was jointly organized by the Japan Pharmaceutical Manufacturers Association (JPMA) and the Pharmaceutical and Medical Device Regulatory Science Society of Japan (PMRJ, non-profit organization), and supported by Ministry of Health, Labour and Welfare (MHLW), the Federation of Pharmaceutical Manufacturers’ Associations of Japan, the Pharmaceutical Manufacturers’ Association of Tokyo, Osaka Pharmaceutical Manufacturers Association and Japan Pharmaceutical Association.

       

      More information on this meeting can be found on the JPMA website.

    • Location :

      Paris, France

      Date :

      13 April 2015

      Description :

      The public meeting entitled "Information Day on ICH" is organised by the Drug Information Association (DIA) in collaboration with the European Commission (EC) and the European Medicines Agency (EMA). It provides an opportunity for members of the ICH to update stakeholders on the status of active topics and potential new topics to be harmonised as well as on some key reforms of ICH in terms of governance, new membership and funding.

       

      The meeting is open to professionals in regulatory affairs, regulatory submissions, pharmacovigilance, toxicology and quality assurance / quality control from industry and drug regulatory authorities, who are interested in being updated on the future of ICH and the status of active ICH topics. More information on this meeting can be found on the DIA website.

    • Location :

      Tokyo, Japan

      Date :

      11 December 2014

      Description :

      The 31st ICH public meeting was held in Japan at the Nagai Kinen Hall, Shibuya-ku in Tokyo on 11 December 2014.

      This public meeting provides an opportunity to update the public on the information of the progress made during the ICH meeting in Lisbon in November 2014. Presentations were made on the current discussions on ICH Reforms and recent development of ICH followed by an update on the status of various ICH Guidelines under development, ending with a Q&A session.

      The public meeting is jointly organised by the Japan Pharmaceutical Manufacturers Association (JPMA) and the Pharmaceutical and Medical Device Regulatory Science Society of Japan (PMRJ, non-profit organization), and supported by the Federation of Pharmaceutical Manufacturers’ Associations of Japan, the Pharmaceutical Manufacturers’ Association of Tokyo, Osaka Pharmaceutical Manufacturers Association and Japan Pharmaceutical Association.

      More information on this meeting can be found on the JPMA website.

    • Location :

      Tokyo, Japan

      Date :

      10 July 2014

      Description :

      The 30th ICH public meeting was held in Japan at the Nagai Kinen Hall, Shibuya-ku in Tokyo on 10 July 2014.

      This public meeting provided an opportunity to update the public on the progress made during the ICH meeting in Minneapolis from in early June 2014 and on the status of the various ICH Guidelines under development with a Q&A session.

      The public meeting was jointly organised by the Japan Pharmaceutical Manufacturers Association (JPMA) and the Pharmaceutical and Medical Device Regulatory Science Society of Japan (PMRJ, non-profit organisation), and supported by the Federation of Pharmaceutical Manufacturers’ Associations of Japan, the Pharmaceutical Manufacturers’ Association of Tokyo, Osaka Pharmaceutical Manufacturers Association and Japan Pharmaceutical Association.

      More information on this meeting can be found on the JPMA website.

    • Location :

      Vienna, Austria

      Date :

      28 March 2014

      Description :

      The public meeting entitled "Information Day on ICH" is co-organised by EFPIA and DIA and is intended to provide an update on the status of active topics and potential new topics to be harmonised as well as an update on ICH reforms, including increased transparency, new membership, restructured governance and future funding models.

      The meeting is open to professionals in regulatory affairs, regulatory submissions, pharmacovigilance, toxicology and quality assurance / quality control from industry and drug regulatory authorities, who are interested in being updated on the future of ICH and the status of active ICH topics.

      More information on this meeting can be found on the DIA website.

    • Location :

      Tokyo, Japan

      Date :

      10 December 2013

      Description :

      The meeting entitled "ICH Japan Symposium 2013" was the fifth regional meeting of this type held in Japan and took place in Tokyo in December 2013. The Symposium provided an opportunity to update the public on the progress made during the ICH meeting in Osaka in November 2013 and on the status of the various ICH Guidelines under development. It was also an opportunity for participants and the ICH experts/rapporteurs to have a face to face Q&As session on all topics discussed at the Osaka Meetings.

      The Symposium was jointly organised by the Japan Pharmaceutical Manufacturers Association (JPMA) and the Pharmaceutical and Medical Device Regulatory Science Society of Japan (PMRJ, non-profit organisation), and supported by the Ministry of Health, Labour and Welfare (MHLW), the Federation of Pharmaceutical Manufacturers’ Association of Japan, the Pharmaceutical Manufacturers’ Association of Tokyo, the Osaka Pharmaceutical Manufacturers Association and the Japan Pharmaceutical Association.

      More information on this meeting can be found on the JPMA website.

    • Location :

      Tokyo, Japan

      Date :

      26 July 2013

      Description :

      The 28th ICH Public Meeting in Japan was held at the Tsuda Hall, Shibuya-ku in Tokyo in July 2013. It was an opportunity to update the public on the progress made during the ICH meeting in Brussels, Belgium in June 2013 and on the status of the various ICH Guidelines under development. It was also an opportunity for participants and the ICH experts/rapporteurs to have a face to face Q&As session on all topics discussed at the Brussels Meetings.

      The workshop was jointly organised by the Japan Pharmaceutical Manufacturers Association (JPMA) and the Pharmaceutical and Medical Device Regulatory Science Society of Japan (PMRJ, non-profit organisation), and supported by the Federation of Pharmaceutical Manufacturers’ Association of Japan, the Pharmaceutical Manufacturers’ Association of Tokyo, the Osaka Pharmaceutical Manufacturers Association and the Japan Pharmaceutical Association.

      All information as well as the presentations presented at the workshop are available on the JPMA website.

    • Location :

      Tokyo, Japan

      Date :

      25 July 2012

      Description :

      The meeting entitled "ICH Japan Symposium 2012" is the fourth regional ICH public meeting held in Japan which took place at the Tsuda Hall, Shibuya-ku in Tokyo in July 2012.

      The Symposium provide an opportunity to update the public on the progress made during the ICH meeting in Fukuoka in June 2012 and on the status of the various ICH Guidelines under development. It was also an opportunity for participants and the ICH experts/rapporteurs to have a face to face Q&As session on all topics discussed at the Fukuoka Meetings.

      The Symposium was jointly organised by the Japan Pharmaceutical Manufacturers Association (JPMA) and the Pharmaceutical and Medical Device Regulatory Science Society of Japan (PMRJ, non-profit organisation), and supported by the Ministry of Health, Labour and Welfare (MHLW), the Federation of Pharmaceutical Manufacturers’ Association of Japan, the Pharmaceutical Manufacturers’ Association of Tokyo, the Osaka Pharmaceutical Manufacturers Association and the Japan Pharmaceutical Association.

      All information as well as the presentations presented at the symposium are available on the JPMA website.

    • Location :

      Silver Spring, Maryland, US

      Date :

      14 May 2012

      Description :

      A public meeting entitled “Preparation for ICH Steering Committee and Expert Working Group Meetings in Fukuoka, Japan” was held on 14 May 2012, in Silver Spring, Maryland. The meeting which was hosted by FDA with participation from Health Canada and PhRMA, provided information on the ICH in general as well as the ICH Steering Committee and Expert Working Group meetings in Fukuoka, Japan, on 2-7 June 2012. The topics discussed at the public meeting were the topics for discussion at the Cincinnati meeting, and the purpose of the meeting was to solicit public input prior to the meeting.

    • Location :

      Rockville, Maryland, US

      Date :

      25 October 2011

      Description :

      A public meeting entitled “Preparation for ICH Steering Committee and Expert Working Group Meetings in Cincinnati, Ohio” was held on 19 May 2011, in Rockville, Maryland. The meeting which was co-hosted by FDA and PhRMA, and with participation from Health Canada, provided information on the ICH as well as the ICH Steering Committee and Expert Working Group meetings that was going to take place in Seville, Spain, on 5-10 November 2011. The topics discussed at the public meeting were the topics for discussion at the Seville meeting, and the purpose of the meeting was be solicit public input prior to the meeting.

    • Location :

      Rockville, Maryland, US

      Date :

      19 May 2011

      Description :

      A public meeting entitled “Preparation for ICH Steering Committee and Expert Working Group Meetings in Cincinnati, Ohio” was held on 19 May 2011, in Rockville, Maryland. The meeting which was co-hosted by FDA and PhRMA, and with participation from Health Canada, provided information on the ICH as well as the ICH Steering Committee and Expert Working Group meetings in Cincinnati, Ohio, on 11-16 June 2011. The topics discussed at the public meeting were the topics for discussion at the Cincinnati meeting, and the purpose of the meeting was be solicit public input prior to the meeting.

    • Location :

      Washington DC, Maryland, US

      Date :

      21 October 2008

      Description :

      The first U.S. regional public ICH meeting, hosted by the U.S. Food and Drug Administration (FDA) and the Pharmaceutical Research and Manufacturers of America (PhRMA) took place at the Hilton Washington DC / Rockville Hotel & Executive Meeting Center, Regency Room, 1750 Rockville Pike, Rockville, MD 20852, on Tuesday, 21 October 2008.

    • Location :

      Brussels, Belgium

      Date :

      14 November 2008

      Description :

      The first European regional public ICH meeting took place at the Radisson SAS Hotel in Brussels on 14 November 2008.

      This public ICH meeting provided an opportunity to be informed on the recent developments at ICH in the context of globalisation and increasing international inter-agency cooperation. It also provided an opportunity to receive the latest news on "hot topics", to make comments to the ICH experts and rapporteurs and to raise questions on quality topics, standards development topics and efficacy topics.

      This event gave participants the opportunity to meet with regulators and industry experts from both ICH and non-ICH regions.

    • Location :

      Tokyo, Japan

      Date :

      2 December 2010

      Description :

      The meeting entitled "ICH Japan Symposium 2010" is the third regional ICH public meeting held in Japan which took place at the Tsuda Hall, Shibuya-ku in Tokyo in December 2010.

      The Symposium aimed to provide an opportunity to update the public on the progress made during the ICH meeting in Fukuoka in November 2010 and on the status of the various ICH Guidelines under development. It was also an opportunity for participants and the ICH experts/rapporteurs to have a face to face Q&As session on all topics discussed at the Fukuoka Meetings.

      The Symposium was well attended with over 230 participants from the regulatory authorities and the pharmaceutical industry. The participants had the opportunity to receive an update on the progress, to enhance the mutual understanding, and to meet with ICH regulators and industry experts from the region.

      The Symposium was jointly organised by the Japan Pharmaceutical Manufacturers Association (JPMA) and the Pharmaceutical and Medical Device Regulatory Science Society of Japan (PMRJ, non-profit organisation), and supported by the Ministry of Health, Labour and Welfare (MHLW), the Federation of Pharmaceutical Manufacturers’ Association of Japan, the Pharmaceutical Manufacturers’ Association of Tokyo, the Osaka Pharmaceutical Manufacturers Association and the Japan Pharmaceutical Association.

      All information as well as the presentations used at the symposium are available on the JPMA website.

    • Location :

      Tokyo, Japan

      Date :

      12 June 2009

      Description :

      The meeting entitled "ICH Japan Symposium 2009" is the second regional ICH public meeting held in Japan which took place at the Tower Hall Funabori in Tokyo on June 12, 2009, the following day of the ICH Yokohama Meeting (June 6 - 11, 2009). The Symposium aimed to provide an opportunity to update to the public on the progress made during the ICH meeting in Yokohama and on the status of the various ICH guidelines under development. It also aimed to provide an opportunity for participants and the ICH experts/rapporteurs to have a Q&A on a face-to-face basis on all the topics discussed at the Yokohama Meeting.

    • Location :

      Tokyo, Japan

      Date :

      2 November 2007

      Description :

      Based on the decision of the Steering Committee, the first regional ICH public meeting was held in Tokyo, Japan on November 2, 2007, following the ICH Steering Committee meeting in Yokohama. The meeting entitled "ICH Tokyo Symposium: Hot Topics and Influence on Asia", was a great success attracting a large number of participants.